OTUD6B
protein-codingOTU deubiquitinase 6B, the group of OTU domain containing
Gene summary
This gene encodes a member of the ovarian tumor domain (OTU)-containing subfamily of deubiquitinating enzymes. Deubiquitinating enzymes are primarily involved in removing ubiquitin from proteins targeted for degradation. This protein may function as a negative regulator of the cell cycle in B cells. [provided by RefSeq, Nov 2013]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~16.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0000508
Submitter: ClinGen
*OTUD6B* was first reported in relation to autosomal recessive syndromic intellectual disability in 2017; this condition is also referred to as intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies (Santiago-Sim et al., PMID: 28343629). Individuals with variants in *OTUD6B* have been reported to present with intellectual disability, speech delay, seizures, microcephaly, gross motor delay, intrauterine growth restriction, feeding difficulties, facial dysmorphism, and various, nonspecific abnormalities of the fingers/toes. This curation includes seven predicted null variants (nonsense, frameshift, splice) from 6 probands in 4 publications (PMIDs: 28343629, 34354232, 32181568, 30364145). Additional evidence (including individuals with putative loss of function and missense variants) has been reported in the literature (PMIDs: 30364145, 35707595, 35707595, 35430327, 32924626, 31147255), but these cases were not scored as the maximum for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity appears to be loss of function. Segregation of variants with disease in multiple families also supports this gene-disease relationship (PMIDs: 28343629, 34354232). This gene-disease relationship is also supported by experimental evidence including an animal model and functional alteration studies using patient cells (PMID: 28343629). In summary, there is definitive evidence supporting the relationship between *OTUD6B* and autosomal recessive syndromic intellectual disability. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen ID Autism GCEP on the meeting date 08/22/2024 (SOP Version 10).
Inheritance Pattern: AR
Disease ID:MONDO:0044319
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0044319
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0044319
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to OTUD6B variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_016023.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 6 | 7 | |||
| missense | 5 | 50 | 3 | 58 | ||
| nonsense | 4 | 2 | 3 | 9 | ||
| start loss | 0 | |||||
| frameshift | 5 | 2 | 1 | 8 | ||
| splice donor/acceptor (+/-2bp) | 3 | 5 | 8 | |||
| Total | 12 | 9 | 60 | 9 | 0 | 90 |
Highest pathogenic variant AF is 0.000115809424
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_057107.4 | 7 | MANE Select | |
| Ensembl | ENSP00000384190.4 | 7 | MANE Select | |
| RefSeq | NP_001273674.1 | 5 | Standard | |
| RefSeq | NP_001402951.1 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- EGFR1
Biological Process
- cell population proliferation
- protein deubiquitination
- proteasome assembly
Molecular Function
- thiol-dependent ubiquitin-specific protease activity
- thiol-dependent ubiquitinyl hydrolase activity
Cellular Component
- eukaryotic translation initiation factor 4F complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000285420
- Coding exons
- 7
- Length
- 16900
- Individuals with no LoFs
- 125523
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 70
- Defined
- 125593
- p
- 0.000279
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.296 | 145 | 155 | 0.933 | 0.00000738 | 2084 |
| Missense (PolyPhen) | 53 | 61.541 | 0.86121 | 858 | ||
| Synonymous | -0.0496 | 55 | 54.5 | 1.01 | 0.00000257 | 576 |
| Loss of Function | 0.650 | 12 | 14.7 | 0.817 | 6.91e-7 | 218 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00020 | 0.00012 | rare |
| Latino/Admixed American | 0.0010 | 0.00087 | rare |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.00055 | 0.00054 | rare |
| Finnish | 0.000093 | 0.000092 | rare |
| European (Non-Finnish) | 0.00016 | 0.00015 | rare |
| South Asian | 0.00014 | 0.00013 | rare |
| Other | 0.00077 | 0.00065 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Isoform 1: Deubiquitinating enzyme that may play a role in the ubiquitin-dependent regulation of protein synthesis, downstream of mTORC1 (PubMed:21267069, PubMed:27864334). May associate with the protein synthesis initiation complex and modify its ubiquitination to repress translation (PubMed:27864334). May also repress DNA synthesis and modify different cellular targets thereby regulating cell growth and proliferation (PubMed:27864334). May also play a role in proteasome assembly and function (PubMed:28343629). {ECO:0000269|PubMed:21267069, ECO:0000269|PubMed:27864334, ECO:0000269|PubMed:28343629}.;
- Disease
- DISEASE: Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies (IDDFSDA) [MIM:617452]: An autosomal recessive severe multisystem disorder characterized by poor overall growth, developmental delay, early- onset seizures, intellectual disability, and dysmorphic features. Additional features include microcephaly, absent speech, hypotonia, feeding difficulties, structural brain abnormalities, congenital malformations including congenital heart disease, and musculoskeletal features. {ECO:0000269|PubMed:28343629}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0953
Intolerance Scores
- LoFtool
- 0.587
- RVIS EVS
- 0.71
- RVIS percentile EVS
- 85.53
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.574
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |